We are Chelonia Applied Science, a competence center and interdisciplinary globally distributed team physically hosted at Innovation Office of University of Basel. We investigate novel concepts that underlie the complexities of disruptive innovations, we disseminate and exploit the results of R&D platforms. Our activity is supported by funding from the governments and a number of foundations or large companies.
Chelonia fields of interest
across sectors and geographies seeking to identify R&D platforms
and to advise leaders and big players with highest growth potential of our generation
Energy Production and Storage
Interact with our team. Join conversation on social channels @cheloniaswiss
"Disruptive innovation is often not identified and not priced correctly by the market because people may not understand how big the ultimate opportunities are going to be. They aren't sizing the opportunity and they aren't analyzing the disruption."
Silvano Coletti, Founder & Executive Director, Chelonia SA
Developing Digital Prowess, Horasis Extraordinary Meeting
October 1st, 2020
Applied Science at Chelonia
Spun-out from a venture partially owned by NOMURA, the bank of Japan, for more than 2 decades Chelonia has been an uninterrupted engine of breakthrough innovation. It is not a discovery science organization, but neither is it a pure application organization. It sits firmly at the intersection of the two.
Expanding Basic Science and Solving Society’s Problems
The late political scientist Donald E. Stokes distinguished four categories of research and highlighted how basic science can be employed to create practical applications.
Work here is curiosity-driven basic research, which seeks foundational knowledge without consideration of practical use. This quadrant is named for the early-20th-century atomic physicist Niels Bohr.
This category is pure applied research, aimed at finding a solution to a practical problem, and has no interest in explaining or understanding the phenomena of a scientific field. It’s named for the inventor Thomas Edison.
Research here expands basic scientific knowledge in order to meet pressing societal needs. This quadrant is named for Louis Pasteur, a founder of the field of microbiology, who invented ways to prevent disease and food spoilage.
Stokes didn’t bother to give the fourth quadrant a label; both the science and the use here tend to be uninteresting.
The right Leadership.
Led by founder, Silvano Coletti, who collaborated with some of the most brilliant minds and scientists of last century as 1977 Nobel Laureate Ilya Prigogine, is engineer and internationally recognized innovation-driven entrepreneur, business executive and strategist. He built and led advanced project organizations at listed corporations and Fortune500.
The scientific committee is chaired by Prof. Arieh Warshel - Nobel Laureate 2013 in Chemistry and one of the most influential scientist in the drug discovery industry. He is Distinguished Professor at University of Southern California in Los Angeles. Professor Warshel and his research team leverage their knowledge of chemistry, biology and computer science to simulate biological systems to better understand their structure and function. This methodology has pioneered highly effective models for computer simulations of biological molecules, chemical reactions, and interactive drug therapies. He collaborates at MEDIATE project in the framework of EXSCALATE4COV project backed by EU and participated by Chelonia.
Part of the ATLAS collaboration at CERN's Large Hadron Collider, one of the teams that discovered the Higgs boson in 2012, James Beacham is on the hunt for evidence of new particles -- dark photons, gravitons, dark matter and exotic Higgs bosons among them. James Beacham is staff member and Communication Ambassador-At-Large at Chelonia Applied Science.
Stay ahead of the curve with Chelonia. Monitor breakthrough technologies in 2021
Long- Read Sequencing
Long-read sequencing could provide a more complete picture of the human genome. We believe LR technology offers superior accuracy, more comprehensive variant detection, and a richer set of features than short- read platforms.
Liquid biopsies could prevent more cancer deaths than any medical intervention in history. Based on a single blood test, multi-cancer screening can detect dozens of early stage cancers.
Cell and Gene Therapy 2.0
The 2nd generation of cell and gene therapies should shift from (1) liquid to solid tumors, (2) autologous to allogenic cell therapy and (3) ex vivo to in vivo gene editing.
Deep learning could be the most important software breakthrough of our time. Until recently, humans programmed all software. Deep learning, a form of artificial intelligence (AI), uses data to write software. It could turbocharge every industry.
Space industry is taking off. Rocket and satellite cost declines are upending what once seemed a monopolistic and bureaucratic industry.
The robots are coming. Fears abound that automation will destroy jobs, but Chelonia believes it will empower humans, increasing both productivity and wage growth. Automation has the potential to shift unpaid labor to paid labor. For example. as food services automate, they will transform food prep, cleanup, and grocery shopping into market activities including food delivery.
What to expect from Chelonia.
From accepted mandate or project submission through execution, feedback in days and weeks, not months or years.
Collaborative project adjustments based on the newest results.
Diverse, interdisciplinary efforts.
Active dialogue. Plus continuous meetings for the entire project team.
Expert, objective selection.
Not a consensus-driven review process for programs or proposals.
Programs stop when, together, we run out of ideas. Not when the first idea doesn’t work.
Transition support, because it’s not enough to find a solution, that solution has to find a way into the world.